Genomics

Dataset Information

0

RS07910/07915 TCS multipath regulates clavulanic acid metabolic pathways in Streptomyces clavuligerus F613-1


ABSTRACT: Streptomyces clavuligerus F613-1 produces a clinically important β-lactamase inhibitor, clavulanic acid (CA). The biosynthesis pathway of CA has been basically elucidated, however, the global regulation of CA biosynthesis remains unclear. In order to further elucidate the regulatory mechanism of clavulanic acid synthesis, TCS RS07910/07915 which is next to the CA biosynthetic gene cluster was deleted in Streptomyces clavuligerus. F613-1. Deletion of RS07910/07915 results in decreased the production of CA, but the phenotype was not affected. Both the transcriptome and ChIP-seq data revealed that the TCS RS07910/07915 mainly regulate genes involved in primary metabolism (such as fatty acid degradation, glyceraldehyde 3-phosphate (G3P) metabolism, arginine biosynthesis) and CA biosynthesis. EMSA assays revealed that RS07915 could bind to the promoter fragments of argG, argC, oat1, oat2, ceaS1 and claR in vitro, indicating that RS07915 could direct regulate the biosynthesis genes of arginine and CA. This study indicated that RS07910/07915 is a pleiotropy regulatory TCS, RS07910/07915 could directly affect the biosynthesis of CA, and indirectly affect CA production through affecting primary metabolism of arginine and G3P (precursors of CA).

ORGANISM(S): Streptomyces clavuligerus

PROVIDER: GSE119208 | GEO | 2018/08/30

REPOSITORIES: GEO

Similar Datasets

2022-11-02 | PXD032272 | Pride
2022-08-25 | GSE211765 | GEO
2022-12-08 | MTBLS5744 | MetaboLights
| E-GEOD-24033 | biostudies-arrayexpress
| PRJNA488466 | ENA
| E-GEOD-66683 | biostudies-arrayexpress
2010-11-10 | GSE24033 | GEO
| E-GEOD-51435 | biostudies-arrayexpress
2015-08-05 | GSE66683 | GEO
2018-09-26 | GSE99917 | GEO